Manganese X Energy Corp said its wholly-owned subsidiary, Disruptive Battery Corp, together with its US joint venture partner, PureBiotic AIR, Corp, plan to seek approvals for their Mist Solutions after receiving additional positive results from an ongoing long-term research study conducted by Virginia State University (VSU).
Following the results, which come despite the delays caused by coronavirus (COVID-19) restrictions that have affected most university campuses and research facilities, the firm said it will soon announce a series of registrations, certifications and regulatory product applications of significant interest.
"We continue to evolve our misting solution for the mitigation of pathogens including COVID-19. Research is showing positive efficacy,” CEO Martin Kepman said in a statement.
“We are now moving towards making additional certifications including applying for FDA approval.”
READ: Manganese X Energy says phased test work is progressing well at Battery Hill
In the VSU's latest round of testing, Manganese X said the priority was documenting the risk reduction on an important range of pathogens and biofilm, including COVID-19, utilizing the PureBiotic Mist Solution on surfaces, in addition to air.
It said the VSU researchers produced effective and encouraging results on the PureBiotics Solution's effect on biofilm.
“This is important to note since the Centers for Disease Control and Prevention (CDC) has rated biofilm, where pathogens like COVID-19 and other pathogens are found, to be responsible for some 80% of all infections,” the company said.
“Biofilm provides a protective environment for pathogens from disinfectants and antibiotics. The deconstruction of biofilm removes the "protective home" and therefore helps protect against COVID-19 and other contaminants.”
Also of importance, it said the University laboratory was able to recently produce growths of different types of biofilms required for testing of the PureBiotic AIR HVAC Delivery System for the mitigation of other types of infection risks, such as COVID-19. The testing showed that the PureBiotic Mist can be effective in helping to deconstruct biofilm in an HVAC setting.
Additional research has proven that the PureBiotics technology can simply, easily and economically control Salmonella, Escherichia coli (E. coli), Staphylococcus, MRSA 90%, Pseudomonas 82%, Candida spp. 90%, Coliforms 92%, Acinetobacter spp. 78%, amongst others, the company added.
“With these new studies and former research re-confirming the effectiveness of the PureBiotics Technologies, VSU is adding testing sites to their ongoing study,” Manganese X said.
“These tests will determine how economically viable the PureBiotics formulations are in eliminating the risk of infections, with the additional benefits of providing safer, cleaner and odor free facilities.”
Contact the author at stephen.gunnion@proactiveinvestors.com